Cargando…

Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances

Endocrine-disrupting substances (EDS) may have certain biological effects including delayed effects, multigenerational effects, and may display nonmonotonic dose–response (NMDR) relationships that require careful consideration when determining environmental hazards. Endocrine disrupting substances c...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrott, Joanne L, Bjerregaard, Poul, Brugger, Kristin E, Gray, L Earl, Iguchi, Taisen, Kadlec, Sarah M, Weltje, Lennart, Wheeler, James R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215718/
https://www.ncbi.nlm.nih.gov/pubmed/27862884
http://dx.doi.org/10.1002/ieam.1866
_version_ 1783710295860969472
author Parrott, Joanne L
Bjerregaard, Poul
Brugger, Kristin E
Gray, L Earl
Iguchi, Taisen
Kadlec, Sarah M
Weltje, Lennart
Wheeler, James R
author_facet Parrott, Joanne L
Bjerregaard, Poul
Brugger, Kristin E
Gray, L Earl
Iguchi, Taisen
Kadlec, Sarah M
Weltje, Lennart
Wheeler, James R
author_sort Parrott, Joanne L
collection PubMed
description Endocrine-disrupting substances (EDS) may have certain biological effects including delayed effects, multigenerational effects, and may display nonmonotonic dose–response (NMDR) relationships that require careful consideration when determining environmental hazards. Endocrine disrupting substances can have specific and profound effects when exposure occurs during sensitive windows of the life cycle (development, reproduction). This creates the potential for delayed effects that manifest when exposure has ceased, possibly in a different life stage. This potential underscores the need for testing in appropriate (sensitive) life stages and full life cycle designs. Such tests are available in the Organisation for Economic Co-operation and Development (OECD) tool box and should be used to derive endpoints that can be considered protective of all life stages. Similarly, the potential for effects to be manifest in subsequent generations (multigenerational effects) has also been raised as a potential issue in the derivation of appropriate endpoints for EDS. However, multigenerational studies showing increasing sensitivity of successive generations are uncommon. Indeed this is reflected in the design of new higher tier tests to assess endocrine active substances (EAS) that move to extended one-generation designs and away from multi-generational studies. The occurrence of NMDRs is also considered a limiting factor for reliable risk assessment of EDS. Evidence to date indicates NMDRs are more prevalent in in vitro and mechanistic data, not often translating to adverse apical endpoints that would be used in risk assessment. A series of steps to evaluate NMDRs in the context of endocrine hazard and risk assessment procedures is presented. If careful consideration of delayed, multigenerational effects and NMDRs is made, it is feasible to assess environmental endocrine hazards and derive robust apical endpoints for risk assessment procedures ensuring a high level of environmental protection.
format Online
Article
Text
id pubmed-8215718
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-82157182021-06-21 Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances Parrott, Joanne L Bjerregaard, Poul Brugger, Kristin E Gray, L Earl Iguchi, Taisen Kadlec, Sarah M Weltje, Lennart Wheeler, James R Integr Environ Assess Manag Article Endocrine-disrupting substances (EDS) may have certain biological effects including delayed effects, multigenerational effects, and may display nonmonotonic dose–response (NMDR) relationships that require careful consideration when determining environmental hazards. Endocrine disrupting substances can have specific and profound effects when exposure occurs during sensitive windows of the life cycle (development, reproduction). This creates the potential for delayed effects that manifest when exposure has ceased, possibly in a different life stage. This potential underscores the need for testing in appropriate (sensitive) life stages and full life cycle designs. Such tests are available in the Organisation for Economic Co-operation and Development (OECD) tool box and should be used to derive endpoints that can be considered protective of all life stages. Similarly, the potential for effects to be manifest in subsequent generations (multigenerational effects) has also been raised as a potential issue in the derivation of appropriate endpoints for EDS. However, multigenerational studies showing increasing sensitivity of successive generations are uncommon. Indeed this is reflected in the design of new higher tier tests to assess endocrine active substances (EAS) that move to extended one-generation designs and away from multi-generational studies. The occurrence of NMDRs is also considered a limiting factor for reliable risk assessment of EDS. Evidence to date indicates NMDRs are more prevalent in in vitro and mechanistic data, not often translating to adverse apical endpoints that would be used in risk assessment. A series of steps to evaluate NMDRs in the context of endocrine hazard and risk assessment procedures is presented. If careful consideration of delayed, multigenerational effects and NMDRs is made, it is feasible to assess environmental endocrine hazards and derive robust apical endpoints for risk assessment procedures ensuring a high level of environmental protection. 2017-01-18 2017-03 /pmc/articles/PMC8215718/ /pubmed/27862884 http://dx.doi.org/10.1002/ieam.1866 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the Creative Commons Attribution-NonCommercial (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Article
Parrott, Joanne L
Bjerregaard, Poul
Brugger, Kristin E
Gray, L Earl
Iguchi, Taisen
Kadlec, Sarah M
Weltje, Lennart
Wheeler, James R
Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances
title Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances
title_full Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances
title_fullStr Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances
title_full_unstemmed Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances
title_short Uncertainties in Biological Responses that Influence Hazard and Risk Approaches to the Regulation of Endocrine Active Substances
title_sort uncertainties in biological responses that influence hazard and risk approaches to the regulation of endocrine active substances
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215718/
https://www.ncbi.nlm.nih.gov/pubmed/27862884
http://dx.doi.org/10.1002/ieam.1866
work_keys_str_mv AT parrottjoannel uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances
AT bjerregaardpoul uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances
AT bruggerkristine uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances
AT graylearl uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances
AT iguchitaisen uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances
AT kadlecsarahm uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances
AT weltjelennart uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances
AT wheelerjamesr uncertaintiesinbiologicalresponsesthatinfluencehazardandriskapproachestotheregulationofendocrineactivesubstances